Akademisyen
SENEM TEKEOĞLU
DOÇENT
BİRUNİ ÜNİVERSİTESİ MESLEK YÜKSEKOKULU TIBBİ HİZMETLER VE TEKNİKLER BÖLÜMÜ
- Ana Dal Sağlık Bilimleri Temel Alanı
- Yan Dal Romatoloji
Kayıtlı çıktılara kısa bakış — ayrıntılar aşağıda.
- Makale 16
- Proje 0
- Kitap 0
- Bildiri 52
- Patent 0
- Sanatsal 0
Scopus (SJR)
Q1
2
Q2
7
Q3
2
Q4
4
WoS (JCR)
Q1
2
Q2
3
Q3
6
Q4
2
TR Index
6
makale
Alan+yıl+tür normalize OpenAlex yüzdelik — Clarivate ESI / SciVal değildir.
Üst %1 makale
0
Üst %10 makale
2
Ort. yüzdelik
55.7%
Üst %1 payı
0.0%
Üst %10 payı
12.5%
Makaleler
YÖKSİS ve OpenAlex kaynak ayrımıyla makaleler; quartile ve TR Index ile daraltabilirsiniz.
Makale listesi
- 2025 Unveiling malignancy patterns among rheumatology patients: Insights from a retrospective study YÖKSİS TR Index SJR Q4 OpenAlex 6.8%
- 2024 Prevalence and Risk Factors of Cardiovascular Disease in Rheumatoid Arthritis Patients: A Comparative Analysis of Real-World Data YÖKSİS SJR Q2 JCR Q2 OpenAlex üst %10 OpenAlex 93.4%
- 2024 Analysis of clinical, immunological characteristics, damage, and survival in 300 Turkish systemic lupus erythematosus patients YÖKSİS SJR Q2 JCR Q3 OpenAlex 72.6%
- 2024 Comprehensive analysis of rheumatic diseases, comorbidities, and mortality in geriatric population: Real-world data of 515 patients in a single rheumatology clinic YÖKSİS SJR Q3 JCR Q2 OpenAlex 76.0%
- 2024 Gynecological symptoms in primary and secondary Sjögren's syndrome and the effect of the disease on sexuality YÖKSİS SJR Q1 JCR Q1 OpenAlex 72.5%
- 2024 The frequency of Celiac disease in primary Sjögren’s syndrome YÖKSİS TR Index SJR Q4 OpenAlex 25.3%
- 2024 Anti-C1q in Systemic Lupus Erythematosus Relationship with Clinical Manifestations and Disease Activity YÖKSİS TR Index SJR Q4 JCR Q4 OpenAlex 9.9%
- 2023 Long‐term efficacy of canakinumab in hyperimmunoglobulin D syndrome YÖKSİS SJR Q3 JCR Q2 OpenAlex 58.5%
- 2022 Beta 2 glycoprotein I Valine247Leucine polymorphism in patients with antiphospholipid syndrome YÖKSİS TR Index OpenAlex 15.8%
- 2020 Malignancy and risk factors in systemic sclerosis patients YÖKSİS TR Index SJR Q4 OpenAlex 20.6%
- 2019 Validation of Turkish version of the Scleroderma Health Assessment Questionnaire YÖKSİS SJR Q2 JCR Q3 OpenAlex 73.9%
- 2019 Evaluation of left and right ventricle by two-dimensional speckle tracking echocardiography in systemic sclerosis patients without overt cardiac disease YÖKSİS SJR Q2 JCR Q3 OpenAlex 78.7%
- 2019 TNF-Related Apoptosis-Inducing Ligand Receptor 1 in Patients With Ankylosing Spondylitis YÖKSİS SJR Q2 JCR Q3 OpenAlex 41.8%
- 2019 Are there any differences among psoriasis, psoriatic arthritis and rheumatoid arthritis in terms of metabolic syndrome and cardiovascular risk factors? YÖKSİS TR Index JCR Q4 OpenAlex 80.5%
- 2019 Validation of Turkish version of the Scleroderma Health Assessment Questionnaire YÖKSİS SJR Q2 JCR Q3 OpenAlex 73.9%
- 2016 Comments on development of aortic structural damage aneurysm or dilatation in patients with giant cell arteritis YÖKSİS SJR Q2 JCR Q3
- 2010 Disulfide bond reduction of von Willebrand factor by ADAMTS-13 YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %10 OpenAlex 91.1%